Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ginn

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 1, 2010
Lymphomagenesis in SCID-X1 mice following lentivirus-mediated phenotype correction independent of insertional mutagenesis and gammac overexpressionSamantha L Ginn, Sophia H Y Liao, Allison P Dane, et al.
The Journal of Gene Medicine|April 6, 2007
Lentivirus vector-mediated gene transfer to the developing bronchiolar airway epithelium in the fetal lambZe-Yan Yu, Karen McKay, Peter van Asperen, et al.
Molecular Therapy. Methods & Clinical Development|April 1, 2024
Novel AAV variants with improved tropism for human Schwann cellsMatthieu Drouyer, Tak-Ho Chu, Elodie Labit, et al.
JHEP Reports : Innovation in Hepatology|February 11, 2020
Efficient <i>in vivo</i> editing of OTC-deficient patient-derived primary human hepatocytesSamantha L Ginn, Anais K Amaya, Sophia H Y Liao, et al.
Molecular Cancer|November 13, 2024
The PI3K-AKT-mTOR axis persists as a therapeutic dependency in KRAS<sup>G12D</sup>-driven non-small cell lung cancerW J McDaid, L Wilson, H Adderley, et al.
Molecular Therapy. Nucleic Acids|March 23, 2017
Limiting Thymic Precursor Supply Increases the Risk of Lymphoid Malignancy in Murine X-Linked Severe Combined ImmunodeficiencySamantha L Ginn, Claus V Hallwirth, Sophia H Y Liao, et al.
Molecular Therapy. Methods & Clinical Development|December 12, 2018
Codon-Optimization of Wild-Type Adeno-Associated Virus Capsid Sequences Enhances DNA Family Shuffling while Conserving FunctionalityMarti Cabanes-Creus, Samantha L Ginn, Anais K Amaya, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2015
Coherence analysis discriminates between retroviral integration patterns in CD34(+) cells transduced under differing clinical trial conditionsClaus V Hallwirth, Gagan Garg, Timothy J Peters, et al.
The Medical Journal of Australia|May 4, 2005
Treatment of an infant with X-linked severe combined immunodeficiency (SCID-X1) by gene therapy in AustraliaSamantha L Ginn, Julie A Curtin, Belinda Kramer, et al.
Science Translational Medicine|September 10, 2020
Restoring the natural tropism of AAV2 vectors for human liverMarti Cabanes-Creus, Claus V Hallwirth, Adrian Westhaus, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 1, 2010
Lymphomagenesis in SCID-X1 mice following lentivirus-mediated phenotype correction independent of insertional mutagenesis and gammac overexpressionSamantha L Ginn, Sophia H Y Liao, Allison P Dane, et al.
The Journal of Gene Medicine|April 6, 2007
Lentivirus vector-mediated gene transfer to the developing bronchiolar airway epithelium in the fetal lambZe-Yan Yu, Karen McKay, Peter van Asperen, et al.
Molecular Therapy. Methods & Clinical Development|April 1, 2024
Novel AAV variants with improved tropism for human Schwann cellsMatthieu Drouyer, Tak-Ho Chu, Elodie Labit, et al.
JHEP Reports : Innovation in Hepatology|February 11, 2020
Efficient <i>in vivo</i> editing of OTC-deficient patient-derived primary human hepatocytesSamantha L Ginn, Anais K Amaya, Sophia H Y Liao, et al.
Molecular Cancer|November 13, 2024
The PI3K-AKT-mTOR axis persists as a therapeutic dependency in KRAS<sup>G12D</sup>-driven non-small cell lung cancerW J McDaid, L Wilson, H Adderley, et al.
Molecular Therapy. Nucleic Acids|March 23, 2017
Limiting Thymic Precursor Supply Increases the Risk of Lymphoid Malignancy in Murine X-Linked Severe Combined ImmunodeficiencySamantha L Ginn, Claus V Hallwirth, Sophia H Y Liao, et al.
Molecular Therapy. Methods & Clinical Development|December 12, 2018
Codon-Optimization of Wild-Type Adeno-Associated Virus Capsid Sequences Enhances DNA Family Shuffling while Conserving FunctionalityMarti Cabanes-Creus, Samantha L Ginn, Anais K Amaya, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2015
Coherence analysis discriminates between retroviral integration patterns in CD34(+) cells transduced under differing clinical trial conditionsClaus V Hallwirth, Gagan Garg, Timothy J Peters, et al.
The Medical Journal of Australia|May 4, 2005
Treatment of an infant with X-linked severe combined immunodeficiency (SCID-X1) by gene therapy in AustraliaSamantha L Ginn, Julie A Curtin, Belinda Kramer, et al.
Science Translational Medicine|September 10, 2020
Restoring the natural tropism of AAV2 vectors for human liverMarti Cabanes-Creus, Claus V Hallwirth, Adrian Westhaus, et al.
Pageof 6